{"title":"Enhanced glucose uptake promotes the survival of hepatocellular carcinoma cells following incomplete radiofrequency ablation.","authors":"Xiaofeng Wang, Ting Li, Chao Peng","doi":"10.1080/23723556.2026.2715876","DOIUrl":null,"url":null,"abstract":"<p><p>Incomplete radiofrequency ablation (iRFA) exposes residual hepatocellular carcinoma (HCC) cells to sublethal thermal stress, which triggers metabolic adaptations that support cell survival. In this study, we demonstrate that iRFA significantly enhances glucose uptake in HCC cells, contributing to the suppression of intracellular reactive oxygen species (ROS) and promoting cell viability. Mechanistically, this effect is mediated by the translocation of GLUT4 from the cytoplasm to the plasma membrane, rather than changes in total GLUT4 expression. GLUT4 redistribution under thermal stress facilitates rapid glucose uptake, providing energy and biosynthetic intermediates necessary for survival under adverse microenvironmental conditions. Inhibition of GLUT4-mediated glucose uptake increases ROS accumulation and reduces cell survival, highlighting its critical role in redox homeostasis. Collectively, our findings reveal an iRFA-GLUT4-glucose uptake axis as a key metabolic adaptation pathway that enables residual tumor cells to survive sublethal thermal stress, suggesting that targeting GLUT4 dynamics may represent a potential therapeutic strategy to improve the efficacy of iRFA and prevent tumor recurrence.</p>","PeriodicalId":37292,"journal":{"name":"Molecular and Cellular Oncology","volume":"13 1","pages":"2715876"},"PeriodicalIF":1.9000,"publicationDate":"2026-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13523916/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular and Cellular Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/23723556.2026.2715876","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Incomplete radiofrequency ablation (iRFA) exposes residual hepatocellular carcinoma (HCC) cells to sublethal thermal stress, which triggers metabolic adaptations that support cell survival. In this study, we demonstrate that iRFA significantly enhances glucose uptake in HCC cells, contributing to the suppression of intracellular reactive oxygen species (ROS) and promoting cell viability. Mechanistically, this effect is mediated by the translocation of GLUT4 from the cytoplasm to the plasma membrane, rather than changes in total GLUT4 expression. GLUT4 redistribution under thermal stress facilitates rapid glucose uptake, providing energy and biosynthetic intermediates necessary for survival under adverse microenvironmental conditions. Inhibition of GLUT4-mediated glucose uptake increases ROS accumulation and reduces cell survival, highlighting its critical role in redox homeostasis. Collectively, our findings reveal an iRFA-GLUT4-glucose uptake axis as a key metabolic adaptation pathway that enables residual tumor cells to survive sublethal thermal stress, suggesting that targeting GLUT4 dynamics may represent a potential therapeutic strategy to improve the efficacy of iRFA and prevent tumor recurrence.
期刊介绍:
For a long time, solid neoplasms have been viewed as relatively homogeneous entities composed for the most part of malignant cells. It is now clear that tumors are highly heterogeneous structures that evolve in the context of intimate interactions between cancer cells and endothelial, stromal as well as immune cells. During the past few years, experimental and clinical oncologists have witnessed several conceptual transitions of this type. Molecular and Cellular Oncology (MCO) emerges within this conceptual framework as a high-profile forum for the publication of fundamental, translational and clinical research on cancer. The scope of MCO is broad. Submissions dealing with all aspects of oncogenesis, tumor progression and response to therapy will be welcome, irrespective of whether they focus on solid or hematological neoplasms. MCO has gathered leading scientists with expertise in multiple areas of cancer research and other fields of investigation to constitute a large, interdisciplinary, Editorial Board that will ensure the quality of articles accepted for publication. MCO will publish Original Research Articles, Brief Reports, Reviews, Short Reviews, Commentaries, Author Views (auto-commentaries) and Meeting Reports dealing with all aspects of cancer research.